By quantifying specific autoantibodies in circulating IC, we were able to demonstrate that IC levels of autoantibodies against dsDNA and the SSA/SSB complex were associated with treatment response in belimumab-treated SLE patients. Here, SSB is linked to systemic lupus erythematosus.